Topic · 3 reports

Controlled Substances Act

RegulationWatch reporting on controlled substances act matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. Controlled Substances Act

    CVS agrees to pay $315 million to settle federal opioid dispensing case

    The Justice Department announced that CVS Pharmacy will pay $315 million to resolve Controlled Substances Act and False Claims Act allegations that it filled unlawful opioid prescriptions and billed federal programs for them. CVS admitted no liability and signed a compliance agreement with the DEA.

  2. Controlled Substances Act

    The Justice Department says CVS filled unlawful opioid prescriptions for over a decade. Nearly two years on, nothing is decided.

    The complaint is an allegation, and CVS denies it. It describes a company whose own pharmacists and data raised the alarm.

  3. Controlled Substances Act

    McKesson reported 16 suspicious orders out of 1.6 million. The penalty was $150 million.

    It was the company's second settlement for the same failure. The first, in 2008, had required it to build a monitoring system.